About Quantigen
Quantigen is a company based in Fishers (United States) founded in 2008 was acquired by Versiti in July 2023. Quantigen offers products and services including Method Development, Biomarker Validation, and Assay Optimization. Quantigen operates in a competitive market with competitors including Rejuvenate Bio, Novogene Corporation, Clinical Microbiomics, BGI and Genewiz, among others.
- Headquarter Fishers, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Quantigen, Llc
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Quantigen
Quantigen offers a comprehensive portfolio of products and services, including Method Development, Biomarker Validation, and Assay Optimization.
Develops sample-to-answer methods for biotechnology applications.
Validates biomarkers for preclinical and clinical use.
Optimizes protocols for molecular biology testing.
Funding Insights of Quantigen
Investors in Quantigen
Quantigen has secured backing from 2 investors. Prominent investors backing the company include Versiti and City of Fishers.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
The City of Fishers is managed as a municipal government entity.
|
Locked | Locked | Locked | |
|
Blood bank
|
Locked | Locked | Locked |
Investor details for Quantigen
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Quantigen
Investment portfolio details for Quantigen
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Quantigen
Detailed financials for Quantigen
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Quantigen Comparisons
Peer comparison for Quantigen
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Quantigen
Quantigen operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Rejuvenate Bio, Novogene Corporation, Clinical Microbiomics, BGI and Genewiz, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Gene-editing platform and anti-aging therapy for dogs are developed.
|
|
| Locked | Locked | Locked |
Genomic services and solutions with NGS expertise are provided.
|
|
| Locked | Locked | Locked |
Meta-genomics platforms and services for microbiome studies are provided.
|
|
| Locked | Locked | Locked |
BGI is engaged in genomics and precision medicine solutions.
|
|
| Locked | Locked | Locked |
Genomic services are provided for the life sciences industry.
|
|
| Locked | Locked | Locked |
NGS-based diagnostic solutions for neonatal screening are developed.
|
Detailed competitors of Quantigen
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Quantigen
Complete news archive for Quantigen
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Quantigen
Quantigen was founded in 2008 and raised its 1st funding round 13 years after it was founded.
Quantigen is headquartered in Fishers, United States. It is registered at Fishers, Indiana, United States.
Quantigen was founded in 2008 and is headquartered in Fishers, United States, within the biotechnology sector focused on genomics. Research and diagnostic services are offered, including sample preparation, gene expression and variant assay development, method validation, RNA-seq analysis, genetic variation analytics, and pharmacogenetic screening. Operations emphasize analytics for gene expression and genetic variations to support scientific and clinical applications.
Quantigen's top competitors include Novogene Corporation, BGI and Source BioScience.
Quantigen offers Method Development, Biomarker Validation, and Assay Optimization.
Quantigen has 2 investors. Key investors include Versiti, and City of Fishers.